BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$462M |
| 2 |
UnitedHealth
UNH
|
+$441M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$429M |
| 4 |
Analog Devices
ADI
|
+$347M |
| 5 |
Apple
AAPL
|
+$342M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.7B |
| 2 |
Industrial Select Sector SPDR Fund
XLI
|
+$536M |
| 3 |
Netflix
NFLX
|
+$316M |
| 4 |
PepsiCo
PEP
|
+$293M |
| 5 |
Consumers Staples Select Sector SPDR Fund
XLP
|
+$206M |
Sector Composition
| 1 | Technology | 25.21% |
| 2 | Financials | 10.94% |
| 3 | Healthcare | 10.54% |
| 4 | Consumer Discretionary | 10.46% |
| 5 | Industrials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Ginkgo Bioworks
DNA
$593M
| $2.65M | ﹤0.01% |
465,157
+180,046
| +63% | +$1.03M |
|
1427
First Trust Financials AlphaDEX Fund
FXO
$2.26B
| $2.65M | ﹤0.01% |
50,000
-100,000
| -67% | -$5.3M |
|
1428
Teladoc Health
TDOC
$1.36B
| $2.64M | ﹤0.01% |
332,280
-42,596
| -11% | -$339K |
|
1429
Theravance Biopharma
TBPH
$720M
| $2.64M | ﹤0.01% |
296,172
-9,443
| -3% | -$84.3K |
|
1430
Lufax Holding
LU
$2.61B
| $2.64M | ﹤0.01% |
889,745
-415,730
| -32% | -$1.23M |
|
1431
Descartes Systems
DSGX
$8.96B
| $2.64M | ﹤0.01% |
26,201
+7,588
| +41% | +$765K |
|
1432
Lear
LEA
$5.62B
| $2.64M | ﹤0.01% |
29,899
+11,316
| +61% | +$998K |
|
1433
Westlake Corp
WLK
$11.3B
| $2.64M | ﹤0.01% |
26,356
-48,759
| -65% | -$4.88M |
|
1434
Travere Therapeutics
TVTX
$2.09B
| $2.64M | ﹤0.01% |
147,114
-1,062,696
| -88% | -$19M |
|
1435
Matsons
MATX
$3.29B
| $2.63M | ﹤0.01% |
20,519
+10,754
| +110% | +$1.38M |
|
1436
Premier
PINC
$2.2B
| $2.63M | ﹤0.01% |
136,311
+61,448
| +82% | +$1.18M |
|
1437
National Fuel Gas
NFG
$7.97B
| $2.62M | ﹤0.01% |
33,073
-16,067
| -33% | -$1.27M |
|
1438
TD Synnex
SNX
$12.5B
| $2.61M | ﹤0.01% |
25,116
+6,329
| +34% | +$658K |
|
1439
Rumble
RUM
$2.48B
| $2.61M | ﹤0.01% |
368,761
+367,692
| +34,396% | +$2.6M |
|
1440
BILL Holdings
BILL
$5.19B
| $2.6M | ﹤0.01% |
56,748
-62,422
| -52% | -$2.86M |
|
1441
Starwood Property Trust
STWD
$7.52B
| $2.6M | ﹤0.01% |
131,382
-56,854
| -30% | -$1.12M |
|
1442
Genesis Energy
GEL
$2.03B
| $2.59M | ﹤0.01% |
165,345
+62,749
| +61% | +$985K |
|
1443
Materials Select Sector SPDR Fund
XLB
$5.5B
| $2.59M | ﹤0.01% |
30,141
-2,103,854
| -99% | -$181M |
|
1444
Allegiant Air
ALGT
$1.19B
| $2.59M | ﹤0.01% |
50,138
+48,013
| +2,259% | +$2.48M |
|
1445
Rapid7
RPD
$1.27B
| $2.56M | ﹤0.01% |
96,559
-10,400
| -10% | -$276K |
|
1446
ProShares UltraPro Short S&P 500
SPXU
$505M
| $2.55M | ﹤0.01% |
+100,000
| New | +$2.55M |
|
1447
Core & Main
CNM
$9.28B
| $2.55M | ﹤0.01% |
52,716
+282
| +0.5% | +$13.6K |
|
1448
Bread Financial
BFH
$2.95B
| $2.54M | ﹤0.01% |
50,759
-68,977
| -58% | -$3.45M |
|
1449
Universal Insurance Holdings
UVE
$719M
| $2.52M | ﹤0.01% |
106,222
+473
| +0.4% | +$11.2K |
|
1450
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$574M
| $2.51M | ﹤0.01% |
107,056
+92,317
| +626% | +$2.16M |
|